Pancreatic cancer patients with circulating tumor cells tend to have worse outcomes:
Fox Chase Cancer Center investigators find that pancreatic cancer patients who have circulating tumor cells tend to have worse outcomes than patients without circulating tumor cells.
A blood test for small molecules abnormally expressed in pancreatic cancer may be a promising route to early detection of the disease, researchers at The University of Texas MD Anderson Cancer Center report in the September edition of the journal Cancer Prevention Research.